DK0787796T3 - Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner - Google Patents

Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner

Info

Publication number
DK0787796T3
DK0787796T3 DK96401402T DK96401402T DK0787796T3 DK 0787796 T3 DK0787796 T3 DK 0787796T3 DK 96401402 T DK96401402 T DK 96401402T DK 96401402 T DK96401402 T DK 96401402T DK 0787796 T3 DK0787796 T3 DK 0787796T3
Authority
DK
Denmark
Prior art keywords
hly
prevention
treatment
adenylate cyclase
protective epitopes
Prior art date
Application number
DK96401402T
Other languages
English (en)
Inventor
Nicole Guiso
Fotini Betsou
Peter Sebo
Farida Nato
Stephanie Landais
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0787796T3 publication Critical patent/DK0787796T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria
DK96401402T 1995-06-30 1996-06-25 Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner DK0787796T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507945A FR2736064B1 (fr) 1995-06-30 1995-06-30 Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella

Publications (1)

Publication Number Publication Date
DK0787796T3 true DK0787796T3 (da) 2009-04-20

Family

ID=9480602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96401402T DK0787796T3 (da) 1995-06-30 1996-06-25 Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner

Country Status (11)

Country Link
US (3) US6309648B1 (da)
EP (1) EP0787796B9 (da)
JP (1) JP4302784B2 (da)
AT (1) ATE420951T1 (da)
AU (1) AU5625796A (da)
CA (1) CA2180280A1 (da)
DE (1) DE69637812D1 (da)
DK (1) DK0787796T3 (da)
ES (1) ES2320392T3 (da)
FR (1) FR2736064B1 (da)
PT (1) PT787796E (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US7462472B2 (en) * 2001-11-02 2008-12-09 The University Of Chicago Methods and compositions relating to anthrax pathogenesis
EP1489092A1 (en) * 2003-06-18 2004-12-22 Institut Pasteur Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof
CN101636157A (zh) * 2007-01-12 2010-01-27 康乃尔研究基金会有限公司 作为抗菌干预的新型靶的腺苷酰环化酶
US9095578B2 (en) * 2007-01-12 2015-08-04 Cornell Research Foundation, Inc. Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens
US20100112009A1 (en) * 2008-11-03 2010-05-06 Institut Pasteur Acellular antibordetella vaccine
US11207378B2 (en) 2016-04-04 2021-12-28 University Of Virginia Patent Foundation Compositions for inhibiting formation of and/or disrupting bacterial biofilms and methods of use therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2590483B1 (fr) 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
ATE80179T1 (de) 1986-12-23 1992-09-15 Univ Leland Stanford Junior Modifiziertes pertussistoxin.
ES2091186T3 (es) 1988-04-19 1996-11-01 Pasteur Institut Procedimiento para obtener antigenos protectores contra infecciones y procesos toxicos de bordetella.
EP0338170A1 (en) 1988-04-19 1989-10-25 Institut Pasteur Immunoprotective antigenic protein against pathogenic bacteria
FR2638169B1 (fr) * 1988-10-25 1991-01-11 Pasteur Institut Derives d'adenyl cyclase et leurs utilisations biologiques
FR2646776B1 (fr) 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella

Also Published As

Publication number Publication date
ES2320392T3 (es) 2009-05-21
CA2180280A1 (fr) 1996-12-31
EP0787796B9 (fr) 2009-08-05
EP0787796A1 (fr) 1997-08-06
US7902349B2 (en) 2011-03-08
JPH09187284A (ja) 1997-07-22
US6994854B1 (en) 2006-02-07
US20060292161A1 (en) 2006-12-28
FR2736064A1 (fr) 1997-01-03
PT787796E (pt) 2009-04-03
DE69637812D1 (de) 2009-03-05
FR2736064B1 (fr) 1997-09-05
JP4302784B2 (ja) 2009-07-29
AU5625796A (en) 1997-01-23
US6309648B1 (en) 2001-10-30
ATE420951T1 (de) 2009-01-15
EP0787796B1 (fr) 2009-01-14

Similar Documents

Publication Publication Date Title
Turnbull Anthrax vaccines: past, present and future
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
DK0612250T3 (da) Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
DK0787796T3 (da) Beskyttende epitoper fra adenylat-cyclase-hæmolysin (AC-Hly) og deres anvendelse til behandling eller forebyggelse af Bordetella-infektioner
DE761230T1 (de) Aus Bordetella pertussis Aussenmembranprotein enthaltender Impfstoffe und Verfahren zu seiner Herstellung
NO984244D0 (no) Vaksinesammensetninger og fremgangsmÕter som er nyttige i Õ indusere immunbeskyttelse mot artritogene peptider som er involvert i patogenese av reumatoid artritt
ATE62270T1 (de) Herstellung des e.coli-lt-benterotoxinunterteils.
ATE140729T1 (de) Verfahren zur gewinnung von schutzantigenen gegen bordetella-infektionen und toxische prozesse
DE69227984T2 (de) Impfstoff, der eine Untereinheit des menschlichen Transferrin-Rezeptors von Neisseria meningitidis enthält
Finger et al. Bordetella
DK601687D0 (da) Rensede adenyl-cyclase-praeparater, fremgangsmaade til opnaaelse af saadanne praeparater og deres biologiske anvendelser
ATE115861T1 (de) Verwendung von adenylzyclase als vakzin gegen bordetella.
DK1005487T3 (da) Ydre 74 kD-membranprotein fra Moraxella catarrhalis
Gross et al. Differential regulation of Bordetella pertussis virulence factors
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
Gross et al. Virulence regulation in Bordetella pertussis
WHITE et al. A Report from the 50th Anniversary of the Conjoint Meeting on Infectious Diseases
Fernald Immunological control of Mycoplasma infection: A review.